The fractional exhaled nitric oxide (FeNO) breath analyzer market size reached US$ 56.4 Million in 2023. Looking forward, Reports and Insights expects the market to reach US$ 201.5 Million by 2032, exhibiting a growth rate (CAGR) of 15.2% during 2024-2032.
Fractional Exhaled Nitric Oxide (FeNO) breath analyzers are designed to measure the level of nitric oxide in a person’s breath. Nitric oxide is an important biomarker for airway inflammation, particularly in individuals with asthma.